Stanozolol (Winstrol) 50mg

Stanozolol (Winstrol) 50mg Overview | iRoids Pharma

Stanozolol 50mg is an oral anabolic steroid tablet containing 50mg of Stanozolol per tablet, the active anabolic compound commonly known by its original brand name Winstrol. The 50mg tablet format represents a higher-concentration Stanozolol presentation compared to the standard 10mg tablets widely available in the non-prescription market. At iRoids Pharma, we carry Stanozolol 50mg as part of our oral anabolic steroid inventory for customers in markets where Stanozolol is legally available. Stanozolol has a documented clinical history spanning decades, with physicians originally prescribing it for conditions including hereditary angioedema, anemia, and muscle wasting before most clinical approvals lapsed. Like all anabolic steroid products, Stanozolol 50mg carries significant health and legal considerations that anyone researching it should understand clearly before forming an opinion about it.

Winthrop Laboratories originally developed Stanozolol in the 1960s and introduced it under the brand name Winstrol. It became one of the most widely discussed oral anabolic steroids in both clinical medicine and performance communities over the following decades. Its specific pharmacological profile, including non-aromatizing activity, oral bioavailability, and a relatively favorable anabolic to androgenic ratio, gives it a distinct position in performance community discussions. However, Stanozolol also carries one of the most significant adverse lipid profiles among commonly discussed oral anabolic steroids and significant liver toxicity due to its 17-alpha alkylated structure.

This article provides general educational information about Stanozolol 50mg and Winstrol. It does not constitute medical advice, does not recommend or encourage steroid use, and does not provide dosage or cycle guidance of any kind.

Product Specifications

Website: iroidspharma.com Active Compound: Stanozolol Common Name: Winstrol, Winny Concentration: 50mg per tablet Presentation: Oral tablet Form: Tablet Half-Life: Approximately 9 hours for oral Stanozolol Route of Administration: Oral Anabolic Rating: 320 relative to testosterone baseline of 100 Androgenic Rating: 30 relative to testosterone baseline of 100 Estrogenic Activity: None. Stanozolol does not aromatize to estrogen. Progestogenic Activity: None. Stanozolol does not bind to progesterone receptors. Liver Toxicity: High. Stanozolol is a 17-alpha alkylated compound and carries significant liver toxicity risk. Legal Status: Schedule III controlled substance in the United States. Prescription only.

What Is Stanozolol

Stanozolol is a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Winthrop Laboratories developed it in the early 1960s and it received FDA approval for specific clinical applications. Unlike most anabolic steroids derived from dihydrotestosterone, Stanozolol carries a pyrazol group attached to the steroid A ring. This unique structural modification gives it pharmacological characteristics that distinguish it from other dihydrotestosterone-derived compounds.

Stanozolol does not convert to estrogen through the aromatase enzyme. As a result, users do not experience estrogen-related side effects from Stanozolol use alone. Furthermore, Stanozolol does not bind to progesterone receptors, which distinguishes it from compounds like Trenbolone and Nandrolone that produce progestogenic side effects. These combined characteristics give Stanozolol a distinct side effect profile compared to most other anabolic steroids.

17-Alpha Alkylation and Liver Toxicity

Stanozolol carries 17-alpha alkylation, which allows it to survive oral administration and reach systemic circulation without first-pass liver metabolism breakdown. This structural modification is directly responsible for Stanozolol’s significant liver toxicity. Unlike Oxandrolone, which also carries 17-alpha alkylation but produces relatively mild liver enzyme elevations, Stanozolol is documented in clinical literature as producing more significant liver stress. This liver toxicity distinction is one of the most important differences between Stanozolol and other commonly discussed oral anabolic steroids.

The 50mg Tablet Format

The 50mg tablet format is significantly higher than the standard 10mg tablets commonly available in the market. This higher concentration delivers five times the Stanozolol per tablet compared to standard presentations. Fewer tablets are consequently required to reach a given total intake compared to lower-dose formats. However, the higher concentration per tablet provides less precise dose management flexibility compared to lower-concentration presentations.

Clinical Background of Stanozolol

Stanozolol received FDA approval and was prescribed clinically for several decades before most approvals lapsed. Understanding this clinical history provides relevant context for anyone researching the compound.

Hereditary Angioedema

Stanozolol received FDA approval specifically for the prophylactic treatment of hereditary angioedema. This condition involves recurrent episodes of severe swelling in various body parts. This remains the most well-documented clinical application of Stanozolol and the indication that kept it in legitimate clinical discussions longest. Generic Stanozolol compounding remains available through licensed compounding pharmacies in the United States for this specific clinical indication.

Anemia

Physicians prescribed Stanozolol for aplastic anemia and other anemia conditions due to its erythropoietic effects stimulating red blood cell production. More targeted treatments subsequently replaced it for most anemia applications.

Muscle Wasting Conditions

Stanozolol was prescribed for muscle wasting associated with chronic illness, prolonged corticosteroid use, and other catabolic conditions due to its anabolic effects on lean tissue preservation.

Osteoporosis

Clinical use for osteoporosis management was documented in several countries before more targeted bone-specific therapies replaced it in most protocols.

About Stanozolol 50mg at iRoids Pharma

iRoids Pharma carries Stanozolol 50mg as part of our oral anabolic steroid inventory. The 50mg tablet format represents the higher-concentration Stanozolol option available at iRoids Pharma alongside lower-concentration presentations. Multiple manufacturers produce Stanozolol at the 50mg concentration under various brand names.

At iRoids Pharma, we stock Stanozolol 50mg for customers in markets where the compound is legally available. In the United States, Stanozolol carries Schedule III controlled substance status and requires a valid prescription for legal possession and use. Visit iroidspharma.com to check current availability and pricing.

Why Stanozolol 50mg Appears in Bodybuilding Discussions

Stanozolol occupies a specific and well-defined position in bodybuilding discussions that has remained consistent for decades. Several distinct characteristics drive this consistent discussion.

Non-Aromatizing Profile

Stanozolol does not convert to estrogen. As a result, users do not experience estrogen-related water retention, gynecomastia, or estrogen-driven blood pressure increases from Stanozolol use alone. This characteristic distinguishes it from most other anabolic compounds and makes it a consistent topic in discussions where a dry and lean physical appearance is the goal.

Favorable Anabolic to Androgenic Ratio

The anabolic rating of 320 compared to an androgenic rating of 30 relative to testosterone indicates strong anabolic activity with significantly lower androgenic effects than testosterone. This ratio is frequently cited in bodybuilding literature as a distinguishing characteristic that positions Stanozolol favorably compared to more androgenic compounds at equivalent anabolic activity levels.

No Progestogenic Activity

Stanozolol does not bind to progesterone receptors. This distinguishes it from compounds like Trenbolone and Nandrolone that produce progestogenic side effects including libido suppression and gynecomastia through progestogenic mechanisms. The absence of progestogenic activity is a relevant discussion point in performance communities where managing side effects is a primary consideration.

Lean Tissue Preservation

Stanozolol is frequently discussed in bodybuilding literature in the context of lean tissue preservation during caloric restriction periods. Its anabolic activity without associated water retention makes it a consistent topic in discussions about competition preparation and body composition management where a dry and hard physical appearance is the specific goal.

High Concentration Per Tablet

The 50mg concentration per tablet of this product is one of its primary discussion points in bodybuilding communities. Higher concentration products reduce the number of tablets required to achieve a given total Stanozolol intake. This practical characteristic generates discussion among users who prefer fewer tablets for convenience compared to lower-dose presentations.

Injectable Versus Oral Format

Stanozolol is available in both oral tablet and injectable aqueous suspension forms. Both forms carry similar pharmacological profiles and liver toxicity risks. The oral tablet format of Stanozolol 50mg provides a convenient alternative to injectable Stanozolol for users who prefer oral administration. This format comparison is a consistent discussion point in performance communities researching Stanozolol options.

Stanozolol 50mg Versus Other Oral Anabolic Steroids

Understanding how Stanozolol 50mg compares to other oral anabolic steroids helps clarify its specific position in performance discussions.

Versus Oxandrolone (Anavar)

Oxandrolone does not aromatize to estrogen, similar to Stanozolol. However, it carries significantly lower liver toxicity than Stanozolol and a much lower androgenic rating of 24 compared to Stanozolol’s 30. Furthermore, Oxandrolone retains active FDA approval for multiple clinical indications while Stanozolol’s primary remaining indication is hereditary angioedema. Stanozolol is also associated with joint dryness that Oxandrolone does not typically produce. Both compounds appear in similar bodybuilding contexts due to their non-aromatizing profiles but differ meaningfully in hepatotoxicity characteristics.

Versus Methandrostenolone (Dianabol)

Methandrostenolone aromatizes to estrogen and carries significant liver toxicity comparable to Stanozolol. It produces more rapid and pronounced effects in bodybuilding contexts but generates estrogen-related water retention and gynecomastia that Stanozolol does not. The two compounds represent different pharmacological profiles and are consequently discussed in different bodybuilding contexts.

Versus Turinabol

Turinabol is an oral anabolic steroid that does not aromatize. It carries lower androgenic activity than Stanozolol at a rating of 6 compared to Stanozolol’s 30. Turinabol is also associated with less significant adverse lipid effects than Stanozolol in available research. Both compounds appear in non-aromatizing oral steroid discussions but carry different side effect profiles and androgenic activity levels.

Versus Stanozolol 10mg

The 50mg tablet format contains five times the active compound per tablet compared to standard 10mg presentations. The higher concentration per tablet provides less precise dose management flexibility. The 10mg format consequently provides more precise intake control and is more frequently referenced in clinical and harm reduction discussions.

Risks and Health Considerations

Stanozolol 50mg carries a significant risk profile. Anyone researching this compound should understand these risks clearly before proceeding.

Liver Toxicity

Liver toxicity is the most serious and consistently documented risk associated with Stanozolol use. As a 17-alpha alkylated compound, Stanozolol places direct and significant stress on the liver during metabolism. Clinical literature documents elevated liver enzymes, peliosis hepatis, and in severe cases liver tumors in association with prolonged oral 17-alpha alkylated anabolic steroid use. The liver toxicity associated with Stanozolol is documented as more significant than that of Oxandrolone and comparable to Methandrostenolone in many clinical reports. Regular liver function monitoring is therefore essential for anyone using Stanozolol under medical supervision. The higher 50mg per tablet concentration makes this consideration particularly relevant compared to lower-dose formats.

Cardiovascular Effects

Stanozolol produces some of the most significant adverse lipid effects documented among oral anabolic steroids. Clinical research documents severe reductions in HDL cholesterol and elevations in LDL cholesterol with Stanozolol use. These lipid changes carry significant cardiovascular implications that require monitoring. Regular lipid panel assessment is consequently essential for anyone using Stanozolol under medical supervision.

Joint Dryness

Joint pain and dryness are among the most consistently reported side effects specific to Stanozolol in both clinical literature and user reports. The mechanism relates to Stanozolol’s effect on collagen synthesis and joint fluid dynamics. This side effect distinguishes Stanozolol from most other oral anabolic steroids and is a significant practical consideration for anyone researching the compound.

Hormonal Suppression

Stanozolol suppresses natural testosterone production through feedback inhibition of the hypothalamic-pituitary-gonadal axis. The degree of suppression varies between individuals and depends on duration of use. Natural hormonal function may require medical support to restore after discontinuation.

Androgenic Side Effects

Despite lower androgenic activity than testosterone, Stanozolol still produces androgenic side effects in some individuals. These include acne, oily skin, and in genetically predisposed individuals, acceleration of male pattern hair loss.

Virilization in Women

In women, Stanozolol use carries a significant risk of virilization including voice deepening, clitoral enlargement, increased body hair growth, and disruption of the menstrual cycle. These effects may be irreversible with prolonged use. Women researching this compound should therefore be particularly aware of these risks.

Legal Status

Stanozolol carries Schedule III controlled substance status in the United States. A valid prescription from a licensed physician is required for legal possession and use. Legal status varies by country. Research the legal status in your specific jurisdiction before purchasing from iRoids Pharma.

Frequently Asked Questions About Stanozolol 50mg at iRoids Pharma

Is Stanozolol 50mg Available at iRoids Pharma?

Yes. iRoids Pharma carries Stanozolol 50mg for customers in markets where the compound is legally available. Visit iroidspharma.com to check current availability and pricing.

What Is the Concentration of This Product?

Each tablet contains 50mg of Stanozolol. This is five times the concentration of standard 10mg Stanozolol tablet presentations.

Does Stanozolol Cause Estrogenic Side Effects?

No. Stanozolol does not aromatize to estrogen. Users do not experience estrogen-related side effects including water retention or gynecomastia from Stanozolol use alone. Furthermore, Stanozolol does not bind to progesterone receptors, distinguishing it from progestogenic compounds.

Is Stanozolol Legal to Purchase?

Stanozolol carries Schedule III controlled substance status in the United States and requires a valid prescription. Legal status varies significantly by country. Customers are responsible for confirming the legal status in their specific jurisdiction before purchasing from iRoids Pharma.

What Is the Main Difference Between Winstrol and Anavar?

Both are non-aromatizing oral anabolic steroids. However, Winstrol carries significantly higher liver toxicity and more significant adverse lipid effects than Anavar. Anavar retains active FDA approval for multiple clinical indications while Winstrol’s primary remaining indication is hereditary angioedema. Winstrol is also associated with joint dryness that Anavar does not typically produce.

How Does Stanozolol 50mg Differ From Advar Pharma Winstrol 50?

Both products contain 50mg of Stanozolol per tablet. The distinction is manufacturer identity and brand name. Advar Pharma Winstrol 50 is specifically branded under the Advar Pharma manufacturer name. Both deliver the same active compound at the same concentration.

What to Consider Before Purchasing Stanozolol 50mg

Stanozolol 50mg generates significant discussion across bodybuilding and fitness communities. Clinical discussion draws from decades of documented medical use. Much of the bodybuilding discussion draws from anecdotal sources with variable information quality. Relying on forum-based guidance for health decisions consequently carries real risk.

If you are researching Stanozolol for educational purposes, prioritize peer-reviewed medical research and consult a licensed medical professional. The liver toxicity and cardiovascular risk profile of Stanozolol are among the most significant documented across commonly discussed oral anabolic steroids. No fitness or physique goal justifies using this compound without fully understanding these documented risks. Furthermore, its legal status requires a valid prescription in the United States and many other countries.

For customers in markets where Stanozolol is legally available, visit iroidspharma.com to check current Stanozolol 50mg stock, pricing, and availability.